Shanghai Henlius Biotech has achieved its first full year of profitability in 2023 on the back of increased sales and growing sales volume, marking a change from the last two years’ of reported losses.
The Chinese company reported a net profit of RMB546m ($75.72m) in the reporting period that ended with the turn of...







